Cropel Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 06-07-2024
- Paid Up Capital ₹ 2.00 Cr
as on 06-07-2024
- Company Age 4 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.75 Cr
as on 06-07-2024
- Revenue 1518.14%
(FY 2022)
- Profit 186.29%
(FY 2022)
- Ebitda 5312.55%
(FY 2022)
- Net Worth 6.58%
(FY 2022)
- Total Assets 134.18%
(FY 2022)
About Cropel Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹2.75 Cr.
Prakash Dobariya, Jayantilal Bhuva, Mukeshkumar Vekaria, and Six other members serve as directors at the Company.
- CIN/LLPIN
U24304GJ2020PTC115678
- Company No.
115678
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Aug 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabd, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Cropel Lifesciences?
Board Members(9)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mukeshkumar Vekaria  | Director | 29-Mar-2022 | Current |
| Prakash Dobariya | Director | 29-Mar-2022 | Current |
| Jayantilal Bhuva | Director | 20-Aug-2020 | Current |
| Mahendrakumar Patel | Director | 20-Aug-2020 | Current |
| Kishorkumar Kachhadia | Director | 20-Jul-2022 | Current |
| Alkesh Sangani | Director | 29-Mar-2022 | Current |
Financial Performance and Corporate Structure Insights of Cropel Lifesciences.
Cropel Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 1518.14% increase. The company also saw a substantial improvement in profitability, with a 186.29% increase in profit. The company's net worth moved up by a moderate rise of 6.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cropel Lifesciences?
In 2022, Cropel Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Cropel Agri Seeds & Cold Storage Private LimitedActive 3 years 11 monthsPrakash Dobariya, Jayantilal Bhuva and 6 more are mutual person
- Cropel International Private LimitedActive 4 years 4 months
Prakash Dobariya, Jayantilal Bhuva and 6 more are mutual person
- Colt Hydromatics LlpActive 5 years 2 months
Mukeshkumar Vekaria, Jaysukhbhai Sangani and 1 more are mutual person
- Sharda Organiser & Buildcon Private LimitedActive 16 years 4 months
Mukeshkumar Vekaria is a mutual person
- Odhav Estate Infrastructure Development LimitedActive 18 years 10 months
Mukeshkumar Vekaria is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Bank Creation Date: 01 Nov 2021 | ₹2.75 Cr | Open |
How Many Employees Work at Cropel Lifesciences?
Cropel Lifesciences has a workforce of 0 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cropel Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cropel Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
